Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Neoplasia (New York, N.Y.)|May 22, 2004
Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response markerVicki Plaks, Natalia Koudinova, Uri Nevo, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2009
A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activityYangbing Zhao, Qiong J Wang, Shicheng Yang, et al.Nature Communications|June 15, 2021
P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomasLiat Rousso-Noori, Ignacio Mastandrea, Shauli Talmor, et al.Nano Letters|October 12, 2011
Electrically controlled molecular recognition harnessed to activate a cellular responseArbel Artzy-Schnirman, Dan Blat, Yael Talmon, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 2, 2014
Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholdsRavit Oren, Moran Hod-Marco, Maya Haus-Cohen, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2021
T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric FieldsGil Diamant, Hadar Simchony Goldman, Lital Gasri Plotnitsky, et al.Cancer Immunology Research|October 3, 2020
Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual SpecificityAnat Globerson Levin, Moran Rawet Slobodkin, Tova Waks, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|January 7, 2018
Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancerEva Zupančič, Caterina Curato, Jung-Seok Kim, et al.The Journal of Biological Chemistry|February 9, 2002
Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteinsAnat David, Nicola Mabjeesh, Idit Azar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancerMichael H Kershaw, Jennifer A Westwood, Linda L Parker, et al.Pageof 5